SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
酆老头
Lv2
130 积分
2022-05-11 加入
最近求助
最近应助
互助留言
Pharmacokinetics/Pharmacodynamic (PK/PD) relationship of therapeutic monoclonal antibodies used in oncology: what's new?
8天前
已完结
Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 1, monoclonal antibodies, antibody-drug conjugates and bispecific T-cell engagers
8天前
已完结
Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodies
8天前
已完结
Quantification of follow‐up time in oncology clinical trials with a time‐to‐event endpoint: Asking the right questions
20天前
已完结
A hazard ratio was estimated by a ratio of median survival times, but with considerable uncertainty
20天前
已完结
Durvalumab with chemoradiotherapy for limited-stage small-cell lung cancer
23天前
已完结
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
25天前
已完结
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
25天前
已完结
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
26天前
已完结
Facial Edema Associated with Dasatinib: Case Report with Successful Treatment
1个月前
已完结
没有进行任何应助
帮大忙了
2个月前
帮大忙了
2个月前
帮大忙了
2个月前
速度真快
3个月前
帮大忙了
7个月前
帮大忙了
7个月前
帮大忙了
7个月前
么么哒
8个月前
帮大忙了
8个月前
速度真快
8个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论